Cancer drug approval clears way for 150 jobs boost
GlaxoSmithKline, which plans to introduce five new treatments this year, won US approval to sell the drug Tykerb for breast cancer.
The drug will now be manufactured at the company’s Cork plant.
Lunchtime News
Newsletter
Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.


